183 related articles for article (PubMed ID: 6460973)
1. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
Brogard JM; Comte F; Kopferschmitt J; Dorner M; Lavillaureix
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):340-6. PubMed ID: 6460973
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of mezlocillin in patients with kidney impairment: special reference to hemodialysis and dosage adjustments in relation to renal function.
Brogard JM; Comte F; Spach MO; Lavillaureix J
Chemotherapy; 1982; 28(5):318-26. PubMed ID: 6216076
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function (author's transl)].
Cano JP; Rigault JP; Gevaudan MJ; Saingra S; Murisasco A; Charpin J
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):335-9. PubMed ID: 6460972
[TBL] [Abstract][Full Text] [Related]
4. Cephacetrile--application of pharmacokinetic data to dosage determination.
Brogard JM; Dorner M; Brandt C; Lavillaureix J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):168-76. PubMed ID: 950258
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
[TBL] [Abstract][Full Text] [Related]
6. Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.
Kosmidis J; Doundoulaki P; Stathakis C; Zerefos N; Bounia A; Daikos GK
Arzneimittelforschung; 1979; 29(12a):1960-2. PubMed ID: 543901
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of mezlocillin during haemodialysis.
Thorsteinsson SB; Steingrimsson O; Asmundsson P; Bergan T
Scand J Infect Dis Suppl; 1981; 29():59-63. PubMed ID: 6458883
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
[TBL] [Abstract][Full Text] [Related]
9. Doses of antibiotic in patients with renal insufficiency.
Ohkawa M; Kuroda K
Clin Ther; 1981; 4 Suppl A():124-32. PubMed ID: 6275994
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profile of benoxaprofen in subjects with normal and impaired renal function, prediction of multiple-dose kinetics.
Brogard JM; Comte F; Madon M; Spach MO
Eur J Rheumatol Inflamm; 1982; 5(2):113-23. PubMed ID: 7084275
[TBL] [Abstract][Full Text] [Related]
11. [Benoxaprofene: pharmacokinetic profile in the normal subject and patients with renal insufficiency; evaluation of anticipated serum levels].
Brogard JM; Audhuy B; Spach MO
Schweiz Med Wochenschr; 1981 Feb; 111(6):197-201. PubMed ID: 7221526
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic study of guanfacine in patients with renal insufficiency and in patients under chronic dialysis (author's transl)].
Kiechel JR; Lavene D; Gurret M; Coustenoble J; Petrover M; Godin M; Fillastre JP
Nephrologie; 1980; 1(2):73-81. PubMed ID: 7029332
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of azlocillin in healthy subjects.
Leroy A; Humbert G; Fillastre JP
Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of dibekacin in patients with chronic renal impairment].
Viotte G; Leroy A; Godin M; Fillastre JP
Nouv Presse Med; 1982 Nov; 11(46):3414-8. PubMed ID: 7155849
[TBL] [Abstract][Full Text] [Related]
16. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of iloprost in patients with chronic renal failure and on maintenance haemodialysis.
Hildebrand M; Krause W; Fabian H; Koziol T; Neumayer HH
Int J Clin Pharmacol Res; 1990; 10(5):285-92. PubMed ID: 1706685
[TBL] [Abstract][Full Text] [Related]
18. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
Kampf D; Schurig R; Weihermüller K; Förster D
Antimicrob Agents Chemother; 1980 Jul; 18(1):81-7. PubMed ID: 6448024
[TBL] [Abstract][Full Text] [Related]
19. Overview of acylureidopenicillin pharmacokinetics.
Bergan T
Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of norfloxacin in chronic renal failure.
Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
